Sign in

CIK 0001520262 · Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981007018
Phone
00-353-1-772-8000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,070,874
in 5 filings, $1.1M under 10b5-1 plans

Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Hopkinson Craig C. −$423K EVP R&D, Chief Medical Officer sold 12% of stake
  2. Nichols Christian Todd −$373K SVP, Chief Commercial Officer sold 7% of stake
  3. Gaffin David Joseph −$275K EVP, CLO, Alkermes, Inc. sold 3% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-29 Cooke Shane Director Grant or award · Non Qualified Stock Option (Right to Buy) +12,732 12,732
2023-06-29 Cooke Shane Director Grant or award · Restricted Stock Unit Award +5,985 5,985
2023-06-29 Alva Emily Peterson Director Grant or award · Non Qualified Stock Option (Right to Buy) +12,732 12,732
2023-06-29 Alva Emily Peterson Director Grant or award · Restricted Stock Unit Award +5,985 5,985

Page 41 of 41 · 804 trades